Summit Therapeutics (SMMT) Change in Accured Expenses (2019 - 2025)
Historic Change in Accured Expenses for Summit Therapeutics (SMMT) over the last 7 years, with Q3 2025 value amounting to $945000.0.
- Summit Therapeutics' Change in Accured Expenses fell 8396.67% to $945000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year decrease of 3528.19%. This contributed to the annual value of $11.9 million for FY2024, which is 59974.76% up from last year.
- Summit Therapeutics' Change in Accured Expenses amounted to $945000.0 in Q3 2025, which was down 8396.67% from $14.0 million recorded in Q2 2025.
- Summit Therapeutics' 5-year Change in Accured Expenses high stood at $14.0 million for Q2 2025, and its period low was -$7.6 million during Q1 2025.
- For the 5-year period, Summit Therapeutics' Change in Accured Expenses averaged around $1.4 million, with its median value being $945000.0 (2025).
- Over the last 5 years, Summit Therapeutics' Change in Accured Expenses had its largest YoY gain of 1538857.14% in 2023, and its largest YoY loss of 107945.21% in 2023.
- Summit Therapeutics' Change in Accured Expenses (Quarter) stood at $1.8 million in 2021, then crashed by 101.99% to -$35000.0 in 2022, then skyrocketed by 15388.57% to $5.4 million in 2023, then tumbled by 57.41% to $2.3 million in 2024, then crashed by 58.53% to $945000.0 in 2025.
- Its last three reported values are $945000.0 in Q3 2025, $14.0 million for Q2 2025, and -$7.6 million during Q1 2025.